It is the end of an era for Fujifilm. For decades the Japanese firm has touted computed radiography as the way to transition from film to digital radiography.
It is the end of an era for Fujifilm. For decades the Japanese firm has touted computed radiography as the way to transition from film to digital radiography. But now the company has moved on.
Since obtaining FDA clearance in July to market its portable flat-panel detector in the U.S., Fuji has embraced solid-state electronics as the preferred way to go digital. Fujifilm executives themselves are promoting the new portable detector, called D-EVO (Digital Evolution, which weighs six pounds and measures 14 x 17 inches, as better than computed radiography (CR) for retrofitting film-based radiography rooms.
“CR was really the cost-effective, logical solution for many years and in many situations. But we have seen great demand from our customers and from the market in general to really take advantage of the benefits that DR has to offer,” said Penny Maier, marketing director of imaging systems at Fujifilm Medical USA.
Fuji is entering the DR market with a bang. “D-EVO offers quicker workflow, quicker image availability, and improved image quality,” she said.
It is sobering to hear such a testimonial coming from Fuji, which, more than any other company, made CR a staple of modern x-ray. The company introduced medical CR to the U.S. in 1983. Over the past several decades Fuji has installed more than 35,000 of its CR systems worldwide.
Some hear in Fuji’s move to D-EVO a death knell for CR. But the bell that tolls for CR is a distant one. Just as film has persisted for many years despite digital technologies, CR is likely to continue. Its appeal as an economical way for facilities to enter the digital age will remain intact, especially for low-volume providers.
Can AI Facilitate Improved Dual-Energy X-Ray Screening for Patients at High Risk of Osteoporosis?
June 28th 2024Out of 315 patients identified by artificial intelligence (AI) as being at high risk for osteoporosis, subsequent screening with dual-energy X-ray absorptiometry (DXA) in a randomized controlled trial revealed new-onset osteoporosis in 237 patients.
FDA Clears Mobile C-Arm Device Designed for Complex Vascular Procedures
June 17th 2024Offering a combination of intuitive user-friendly controls and enhanced imaging, the Zenition 90 Motorized C-arm reportedly facilitates workflow efficiencies and bolsters visualization for complex vascular procedures, cardiac interventions, and other clinical procedures.
Qure.ai to Debut Multimodality AI Platform for Lung Cancer Imaging at ASCO 2024
May 29th 2024In addition to detecting missed lung nodules on X-rays, the AI-powered Qure.ai lung cancer continuum platform reportedly automates lung nodule measurement on CT scans and facilitates multimodality reporting.